Log in to save to my catalogue

The updated development of blood-based biomarkers for Huntington’s disease

The updated development of blood-based biomarkers for Huntington’s disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9873222

The updated development of blood-based biomarkers for Huntington’s disease

About this item

Full title

The updated development of blood-based biomarkers for Huntington’s disease

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Journal of neurology, 2023-05, Vol.270 (5), p.2483-2503

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Huntington’s disease is a progressive neurodegenerative disease caused by mutation of the huntingtin (
HTT
) gene. The identification of mutation carriers before symptom onset provides an opportunity to intervene in the early stage of the disease course. Optimal biomarkers are of great value to reflect neuropathological and clinical progressi...

Alternative Titles

Full title

The updated development of blood-based biomarkers for Huntington’s disease

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9873222

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9873222

Other Identifiers

ISSN

0340-5354

E-ISSN

1432-1459

DOI

10.1007/s00415-023-11572-x

How to access this item